CBD products could be prescribed to British patients from as early as next month after the UK government announced plans to lift restrictions on the medical use of cannabis.
The change in policy follows recommendations from the Advisory Council on the Misuse of Drugs (ACMD) and the UK’s Chief Medical Adviser.
The new law will not limit the types of condition that can be considered for treatment with cannabis and cannabis-derivative products. Doctors will no longer need to seek approval from an expert panel in order for patients to access the medicines.
While CBD is not explicitly listed in the legislation, it is understood that it would fall under the umbrella of cannabis-derived medicines.
Sign up to access to our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
